PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110.
In: ACCESSWIRE, 2021-01-04
Zeitungsartikel
Zugriff:
Titel: |
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110.
|
---|---|
Zeitschrift: | ACCESSWIRE, 2021-01-04 |
Veröffentlichung: | 2021 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|